NCT02259803View on ClinicalTrials.gov

Relative Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

November 30, 2007

Conditions
Healthy
Interventions
DRUG

Telmisartan/amlodipine fixed-dose combination (FDC) tablet

DRUG

Telmisartan

DRUG

Amlodipine

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02259803 - Relative Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter